Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 124

Sort by

Sort Order Select

Journal Articles

Comparative analysis of characteristics and outcomes in CD5+/FMC7+ lymphoproliferative disorders and classic CLL immunophenotype patients.

Allison Kagerer, Nikita Malakhov, Caitlin Keenan, Zhengming Chen, Amy Chadburn, Richard Furman, John Allan

Blood (2025) 146 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2025-2121

Published: 2025

Journal Articles

Impact of FMC7 expression on baseline characteristics and outcomes in CLL patients treated with upfront BTKi monotherapy.

Nikita Malakhov, Allison Kagerer, Caitlin Keenan, Zhengming Chen, Amy Chadburn, Richard Furman, John Allan

Blood (2025) 146 (Supplement 1): 2109.

https://doi.org/10.1182/blood-2025-2109

Published: 2025

Journal Articles

ALK+ LBCL and PBL share a similar plasmablastic transcriptional identity but show divergent signaling dependencies and therapeutic vulnerabilities

Blood (2025) 146 (Supplement 1): 51.

https://doi.org/10.1182/blood-2025-51

Published: 2025

Journal Articles

Comparable response rates to therapies in idiopathic multicentric castleman disease patients with and without expert-confirmed diagnoses

Larissa Borys, Bridget Austin, Mary Jo Lechowicz, Sheila Pierson, Kayla McHugh, Abiola Irvine, Kelley Dacus, Adam Bagg, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Joshua Brandstadter, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 6569.

https://doi.org/10.1182/blood-2025-6569

Published: 2025

Journal Articles

Genomic and transcriptomic landscape of extranodal marginal zone lymphoma

Blood (2025) 146 (Supplement 1): 1761.

https://doi.org/10.1182/blood-2025-1761

Published: 2025

Journal Articles

Idiopathic multicentric castleman disease unresponsive to one IL-6 inhibitor may respond to another IL-6 inhibitor

Kayla McHugh, Yuan Huang, Bridget Austin, Larissa Borys, Abiola Irvine, Daisy Alapat, Adam Bagg, Amy Chadburn, Mary Jo Lechowicz, Megan Lim, Gordan Srkalovic, Frits van Rhee, David Fajgenbaum, Lu Zhang, Joshua Brandstadter

Blood (2025) 146 (Supplement 1): 1228.

https://doi.org/10.1182/blood-2025-1228

Published: 2025

Journal Articles

Digital diagnosis: the development of electronic laboratory simulations to promote active learning in hematology among first-year medical students

Raymond Pastore, Amy Chadburn

Blood (2025) 146 (Supplement 1): 6425.

https://doi.org/10.1182/blood-2025-6425

Published: 2025

Journal Articles

Phase II study of polatuzumab in combination with chemoimmunotherapy for richter transformation (PolaR-EPCH).

John Allan, Andrew Lipsky, Seema Bhat, Suchitra Sundaram, Lubing Wu, Jane Matejka, Brittany Hobbie, Nourhan Hamadi, Simone Morris, Zhengming Chen, Ivo Sah Bander, Madhu Ouseph, Jia Ruan, Amy Chadburn, Adam Kittai, Richard Furman

Blood (2025) 146 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2025-3681

Published: 2025

Journal Articles

Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab

Bridget Austin, Saishravan Shyamsundar, Mateo Sarmiento Bustamante, Sheila Pierson, Larissa Borys, Kayla McHugh, Abiola Irvine, Kelley Dacus, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan Lim, Gordan Srkalovic, Frits van Rhee, Joshua Brandstadter, David Fajgenbaum

Blood (2025) 146 (Supplement 1): 3009.

https://doi.org/10.1182/blood-2025-3009

Published: 2025

Journal Articles

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Blood (2025) 146 (Supplement 1): 140.

https://doi.org/10.1182/blood-2025-140

Published: 2025

Journal Articles

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and reed-stenberg cells reveals escape from NK cell recognition and an unfolded protein response

Mikhail Roshal, Isabella Kong, Wikum Dinalankara, Matthew Teater, Bhavneet Bhinder, Sakellarios Zairis, Joshua Brody, Sunita Park, Alexandra Kovach, Matthew Oberley, Megan Lim, Matthew Barth, Olivier Elemento, Ari Melnick, Raul Rabadan, Amy Chadburn, Luigi Marchionni, Lisa Roth, Ethel Cesarman

Blood (2025) 146 (Supplement 1): 3538.

https://doi.org/10.1182/blood-2025-3538

Published: 2025

Journal Articles

Daratumumab with dose-adjusted EPOCH feasibility and early efficacy in newly diagnosed plasmablastic lymphoma: AIDS malignancy consortium 105

Ariela Noy, Stefan Barta, Grace Van Hyfte, Deukwoo Kwon, Robert Baiocchi, Juan Carlos Ramos, Paul Rubinstein, Amy Chadburn, Richard Ambinder

Blood (2025) 146 (Supplement 1): 1970.

https://doi.org/10.1182/blood-2025-1970

Published: 2025

Journal Articles

Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status

Blood (2025) 146 (Supplement 1): 352.

https://doi.org/10.1182/blood-2025-352

Published: 2025

Journal Articles

Single Cell Transcriptome of Epstein Barr Virus-Associated Burkitt Lymphoma from People Living with Human Immunodeficiency Virus

Maria Montserrat Aguilar Hernandez, Isabella Y Kong, Amy Chadburn, Lisa Giulino Roth, Ethel Cesarman

Blood (2024) 144 (Supplement 1): 6195.

https://doi.org/10.1182/blood-2024-212098

Published: 2024

Journal Articles

Daratumumab with Dose-Adjusted EPOCH Is Feasible in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Ariela Noy, Stefan K. Barta, Deukwoo Kwon, Robert Baiocchi, Juan Carlos Ramos, Paul Rubinstein, Amy Chadburn, Richard F. Ambinder

Blood (2024) 144 (Supplement 1): 870.

https://doi.org/10.1182/blood-2024-211388

Published: 2024

Journal Articles

Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma

Caitlin Gribbin, Dylan McNally, Ioannis Karagiannidis, Henna S. Nam, Hiranmayi Ravichandran, Baptiste Brauge, Karin Tarte, Amy Chadburn, Madhu M Ouseph, Sebastian Carrasco, Christian Steidl, David W. Scott, Ari M Melnick, Wendy Béguelin

Blood (2024) 144 (Supplement 1): 739.

https://doi.org/10.1182/blood-2024-198542

Published: 2024

Journal Articles

The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease

Mateo Sarmiento Bustamante, Criswell L. M. Lavery, Adam Bagg, Mary Jo Lechowicz, Daisy V. Alapat, Amy Chadburn, Megan S Lim, Gordan Srkalovic, Frits van Rhee, Joshua D Brandstadter, David C. Fajgenbaum

Blood (2024) 144 (Supplement 1): 1156.

https://doi.org/10.1182/blood-2024-211190

Published: 2024

Journal Articles

Unraveling the Transcriptional Landscape of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: Impact of Tumor Microenvironment and Checkpoint Gene Expression

Blood (2023) 142 (Supplement 1): 176.

https://doi.org/10.1182/blood-2023-182294

Published: 2023

Journal Articles

Acute Leukemias of Ambiguous Lineage Have Durable Response to Hypomethylating Agents Plus Venetoclax in Older Patients

Joshua A Fein, Sanjay Patel, Neela Easwar, Michal Bar-Natan, Amy Chadburn, Pinkal Desai, Julia Geyer, Michael Kluk, Madhu M Ouseph, Ellen K. Ritchie, Michael Samuel, Paul Simonson, Gail J. Roboz, Justin D. Kaner

Blood (2023) 142 (Supplement 1): 1531.

https://doi.org/10.1182/blood-2023-190532

Published: 2023

Journal Articles

Classic Hodgkin Lymphomas Display Neuronal-Glial Lineage Transdifferentiation

Blood (2023) 142 (Supplement 1): 715.

https://doi.org/10.1182/blood-2023-189533

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparative analysis of characteristics and outcomes in CD5+/FMC7+ lymphoproliferative disorders and classic CLL immunophenotype patients.

Impact of FMC7 expression on baseline characteristics and outcomes in CLL patients treated with upfront BTKi monotherapy.

ALK+ LBCL and PBL share a similar plasmablastic transcriptional identity but show divergent signaling dependencies and therapeutic vulnerabilities

Comparable response rates to therapies in idiopathic multicentric castleman disease patients with and without expert-confirmed diagnoses

Genomic and transcriptomic landscape of extranodal marginal zone lymphoma

Idiopathic multicentric castleman disease unresponsive to one IL-6 inhibitor may respond to another IL-6 inhibitor

Digital diagnosis: the development of electronic laboratory simulations to promote active learning in hematology among first-year medical students

Phase II study of polatuzumab in combination with chemoimmunotherapy for richter transformation (PolaR-EPCH).

Pediatric idiopathic multicentric castleman disease is often severe and responds to siltuximab

Spen loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and TLR pathway therapeutic vulnerabilities

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and reed-stenberg cells reveals escape from NK cell recognition and an unfolded protein response

Daratumumab with dose-adjusted EPOCH feasibility and early efficacy in newly diagnosed plasmablastic lymphoma: AIDS malignancy consortium 105

Novel immune gene expression signature risk-stratifies Mantle Cell Lymphoma outcomes independent of TP53 status

Single Cell Transcriptome of Epstein Barr Virus-Associated Burkitt Lymphoma from People Living with Human Immunodeficiency Virus

Daratumumab with Dose-Adjusted EPOCH Is Feasible in Newly Diagnosed Plasmablastic Lymphoma: AIDS Malignancy Consortium 105

Follicular Dendritic Cells Represent a Therapeutic Vulnerability in Early Follicular Lymphoma

The Development of Diagnostic Criteria and Utilization of Excisional Lymph Node Biopsies Shorten Time to Diagnosis for Idiopathic Multicentric Castleman Disease

Unraveling the Transcriptional Landscape of Nodular Lymphocyte-Predominant Hodgkin Lymphoma and T-Cell/Histiocyte Rich Large B-Cell Lymphoma: Impact of Tumor Microenvironment and Checkpoint Gene Expression

Acute Leukemias of Ambiguous Lineage Have Durable Response to Hypomethylating Agents Plus Venetoclax in Older Patients

Classic Hodgkin Lymphomas Display Neuronal-Glial Lineage Transdifferentiation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only